Á½ÐÔÉ«ÎçÒ¹

Roland joined Á½ÐÔÉ«ÎçÒ¹ in 2011, where he teaches Advanced Genetics, Medical Parasitology, and Research Methodology. His NIH-funded research is focused on the molecular mechanism of drug action and resistance in the human malaria parasite, Plasmodium falciparum. His projects are based both in the laboratory and in Africa. Malaria, caused by the blood parasite, Plasmodium falciparum, claims nearly half a million lives and results in hundreds of millions of clinical cases annually, primarily due to the lack of safe, affordable and efficacious drugs available for impoverished populations. Compounding the severity of the problem is the lack of an effective malaria vaccine for the foreseeable future. Antimalarial drugs still offer the best hope for the reduction of morbidity and mortality associated with this disease. Roland is trained in Pharmacology and Toxicology, as well as Public Á½ÐÔÉ«ÎçÒ¹ pertaining to infectious diseases.

Education

National Institutes of Á½ÐÔÉ«ÎçÒ¹, Laboratory of Parasitic Diseases, Post-doctoral Fellowship

University of Arizona, PhD

Harvard School of School of Public Á½ÐÔÉ«ÎçÒ¹, Masters of Public Á½ÐÔÉ«ÎçÒ¹

University of California, Santa Barbara, BS

Research Interests

Together with colleagues from UCSF, Medicines for Malaria Venture, and Brown University we study the emergence of drug resistance to the current arsenal of antimalarial drugs in two sites in Africa: Uganda and Burkina Faso. We are also interested in mechanistic and genomic aspects of new antimalarial compounds in the pre-clinical and clinical pipeline. Many Á½ÐÔÉ«ÎçÒ¹ students have participated in our malaria research, both in the laboratory and field studies in Africa.